Final Conference
27-28 February 2017, Thon City Centre Hotel, Brussels
Addressing Chronic Diseases: How can the EU effectively implement their prevention, management and care across Member States?
JA-CHRODIS’ aim is to contribute to reducing the burden of chronic diseases and to promoting healthy living and active ageing in Europe. Partners gathered highly promising and cost-effective good practices focusing on health promotion and primary prevention as well as the management of multimorbidity and diabetes, with a view to facilitate their exchange and transfer between European countries and regions. 
The one-and-a-half day event will focus on JA-CHRODIS work and outputs and on the bigger picture of the challenge of chronic diseases across Europe. High level speakers, including European Commissioner for Health and Food Safety Vytenis Andriukaitis, will explore how the outcomes of this European collaboration can be used and taken up.
Specifically, based on the evidence that JA-CHRODIS has produced, the final conference will provide a platform for participants to:
Learn how JA-CHRODIS partners captured and facilitated the exchange and transfer of good practices in health promotion and primary prevention, multimorbidity and diabetes;
Consider how healthcare can better integrate health promotion and how healthcare providers can apply a comprehensive care model;
Consider how actors can push forward the development, implementation and sustainability of chronic diseases plans;
Examine how policy makers, healthcare professionals, patients and other stakeholders can move forward the recommendations to effectively prevent and manage chronic diseases across the lifecycle;
Discuss the next steps to be taken to implement policy changes and reduce risk factors of chronic diseases.
Click here for the agenda.
For more information about JA-CHRODIS, please click here.
The final conference is organised as an event of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS), which has received funding from the European Union, in the framework of the Health Programme (2008-2013).
